KYMR stock news · Kymera Therapeutics, Inc.
Get alerts for KYMR
Follow Kymera Therapeutics, Inc. (KYMR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KYMRFree on the App Store and Google Play, or on the web.
Kymera Therapeutics will share results from its KT-621 trial for skin treatment on November 23, 2026.
NeutralKymera scheduled BROADEN2 Phase 2b results for November 23, 2026. No trial findings were announced, so this update does not change the outlook for KYMR.